logo-loader
viewFutura Medical PLC

Futura Medical kicks off process for its ED gel to be approved as medical device

Futura Medical PLC's (LON:FUM) Ken James tells Proactive London's Andrew Scott they've held positive initial discussions with EU regulators as it confirmed it will seek to have its erectile dysfunction (ED) gel approved as a medical device rather than a drug.

The decision to develop the gel as a device follows last year's read-out from the FM57 phase III clinical trial.

Quick facts: Futura Medical PLC

Price: 9.375 GBX

AIM:FUM
Market: AIM
Market Cap: £23.03 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Futura Medical PLC named herein, including the promotion by the Company of Futura Medical PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Futura Medical CEO talks regulatory timeline and commercial potential for...

Futura Medical PLC's (LON:FUM)  James Barder caught up with Proactive London's Andrew Scott on the back of their 2019 results. He says the EU filing for MED3000 is likely by the end of July, with the US Food & Drug Administration submission expected by the end of the third...

2 days, 14 hours ago

2 min read